13G Filing: Park West Asset Management and Eagle Pharmaceuticals, Inc. (EGRX)

Item 4. Ownership.

(a)	Amount Beneficially Owned:		690,000*

(b)	Percent of Class:		4.4%*

(c)	Number of Shares as to which the person has:

	(i)	sole power to vote or to direct the vote:	690,000*

	(ii)	shared power to vote or to direct the vote	0

	(iii)	sole power to dispose or to direct the disposition of:	690,000*

	(iv)	shared power to dispose or to direct the disposition of	0

* This Schedule 13G is being jointly filed by (i) PWAM, a Delaware limited liability company and the investment manager to (a) PWIMF, a Cayman Islands exempted company that is the holder of 606,247 shares of Common Stock of the Company, as reported on this Schedule 13G, and (b) PWPI, a Cayman Islands exempted company that is the holder of 83,753 shares of Common Stock of the Company, as reported on this Schedule 13G; and (ii) Mr. Park, as the sole member and manager of PWAM.

The 690,000 shares of Common Stock held in the aggregate by the PW Funds, which constitute 4.4% of the shares of Common Stock deemed to be outstanding as of December 31, 2015, may be deemed to be beneficially owned (x) indirectly by PWAM, as the investment adviser to PWIMF and PWPI, and (y) indirectly by Mr. Park, as the sole member and manager of PWAM. The foregoing beneficial ownership percentage is based upon 15,589,844 shares of Common Stock of the Company issued and outstanding as of November 10, 2015, based on information reported by the Company in its Quarterly Report on Form 10-Q for the fiscal year ended September 30, 2015, filed with the Securities and Exchange Commission on November 12, 2015.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x

13G Filing: Park West Asset Management and Eagle Pharmaceuticals, Inc. (EGRX)

Published on January 22, 2016 at 3:00 pm by Meena Krishnamsetty in Hedge Funds, News

Page 5 of 9 SEC Filing

Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)

Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on October 30, 2024 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on November 16, 2024 at by Insider Monkey Staff